Compounds > cyc 202
Page last updated: 2024-09-04

cyc 202 and bendamustine

cyc 202 has been researched along with bendamustine in 2 studies

Compound Research Comparison

Studies
(cyc 202)		Trials
(cyc 202)		Recent Studies (post-2010)
(cyc 202)		Studies
(bendamustine)		Trials
(bendamustine)		Recent Studies (post-2010) (bendamustine)
979739324021

Protein Interaction Comparison

ProteinTaxonomycyc 202 (IC50)bendamustine (IC50)
Histone deacetylase 3Homo sapiens (human)0.01
Histone deacetylase 4Homo sapiens (human)0.01
Histone deacetylase 1Homo sapiens (human)0.01
Histone deacetylase 2Homo sapiens (human)0.01
Histone deacetylase 6Homo sapiens (human)0.01
Histone deacetylase 5Homo sapiens (human)0.01

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Davis, MI; Khan, J; Li, SQ; Patel, PR; Shen, M; Sun, H; Thomas, CJ1

Other Studies

2 other study(ies) available for cyc 202 and bendamustine

ArticleYear
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Identification of potent Yes1 kinase inhibitors using a library screening approach.
    Bioorganic & medicinal chemistry letters, 2013, Aug-01, Volume: 23, Issue:15

    Topics: Binding Sites; Cell Line; Cell Survival; Drug Design; Humans; Hydrogen Bonding; Molecular Docking Simulation; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-yes; Small Molecule Libraries; Structure-Activity Relationship

2013